Protective effects of total glucosides of paeony and the underlying mechanisms in carbon tetrachloride-induced experimental liver injury by Qin, Ying & Tian, Ya-ping
Protective effects of total glucosides of paeony and the
underlying mechanisms in carbon tetrachloride-induced
experimental liver injury
Ying Qin, Ya-ping Tian
Abstract
I In nt tr ro od du uc ct ti io on n: :   We explored the protective effects of total glucosides of paeony
(TGP) and the underlying mechanisms in carbon tetrachloride (CCl4)-induced
experimental liver injury in mice.
M Ma at te er ri ia al l   a an nd d   m me et th ho od ds s: :   Chronic liver damage was induced by intraperitoneal
injection of CCl4 (0.5 µl/g) three times per week for 8 weeks. Mice also received
25, 50 or 100 mg/kg TGP. Liver sections were stained with haematoxylin/eosin.
Serum amino transferases, lipid peroxidation and tumour necrosis factor-α
(TNF-α) levels were determined using commercial assays. Quantitative real-time
polymerase chain reaction was used to determine the changes in hepatic 
TNF-α, COX-2, iNOS and HO-1 expression. Protein levels of nitric oxide synthase,
cyclooxygenase-2, haem oxygenase-1 and cytochrome P450 2E1 were determined
by western blotting.
R Re es su ul lt ts s: :   Histological results showed that TGP improved the CCl4-induced changes
in liver structure and alleviated lobular necrosis. The increases in serum protein
and hepatic mRNA expression of TNF-α induced by CCl4 treatment were
suppressed by TGP. Total glucosides of paeony also attenuated the increase the
expression in iNOS and CYP2E1 but augmented the increase in HO-1. The mRNA
and protein expression levels of inducible HO-1 increased significantly after CCl4
treatment.
C Co on nc cl lu us si io on ns s: :   Total glucosides of paeony protects hepatocytes from oxidative
damage induced by CCl4. Total glucosides of paeony may achieve these effects
by enhancing HO-1 expression and inhibiting the expression of proinflammatory
mediators.
K Ke ey y   w wo or rd ds s: :   total glucosides of paeony, liver injury, carbon tetrachloride.
Introduction
Previous studies have shown that carbon tetrachloride (CCl4) enhances
oxidative stress and the recruitment of inflammatory cells and therefore
leads to hepatic architectural and functional damage [1-7]. Carbon
tetrachloride impairs hepatocytes directly by altering the permeability of
the plasma, lysosomal, and mitochondrial membranes. A single dose of
CCl4 may lead to centrizonal necrosis and steatosis [8], while prolonged
administration may induce liver fibrosis, cirrhosis, and even hepatocellular
carcinoma (HCC). The lesions induced by carbon tetrachloride (CCl4)
replicate those seen in most cases of human liver diseases [9]. Therefore,
C Co or rr re es sp po on nd di in ng g   a au ut th ho or r: :
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the experimental model of CCl4-induced hepatic
injury has been used for many years to investigate
the mechanisms involved in acute and chronic liver
injury and to screen hepatoprotective drugs. Carbon
tetrachloride-induced hepatic necrosis involves the
bioactivation of a microsomal cytochrome P450-
dependent mono-oxygenase system, causing the
formation  of  trichloromethyl  free  radicals  and
reactive oxygen species (ROS) that initiate lipid
peroxidation and protein oxidation, resulting in
hepatocellular membrane damage [10]. This process
is  followed  by  the  release  of  inflammatory
mediators from the activated hepatic macrophages,
which  are  thought  to  potentiate  CCl4-induced
hepatic injury.
Paeonia lactiflora pall root, a Chinese traditional
herbal medicine that has anti-inflammatory and
antioxidative actions, has been used as a compo  -
nent of some hepatoprotective herb mixtures in
China, Japan and Korea [11-13]. Total glucosides of
paeony (TGP), extracted from P . lactiflora, contains
paeoniflorin  and  other  components  such  as
hydroxyl-paeoniflorin,  paeonin,  albiflorin,  and
benzoylpaeoniflorin [14]. Paeoniflorin is the main
active  component  of  TGP,  accounting  for
approximately 90% of the constituents of TGP. It
has been shown that TGP has anti-inflammatory,
antioxidative,  hepatoprotective  and  immuno  -
regulatory activities, without evident toxicity or side
effects. Total glucosides of paeony has a long
history of use in traditional Chinese medicine [15],
particularly  for  the  treatment  of  rheumatoid
arthritis and systemic lupus erythematosus, and as
a component of treatments for liver disease.
The present study was designed to evaluate
whether TGP has any beneficial effect on liver
histopathology or liver function in an experimental
model of CCl4-induced chronic liver injury. We also
investigated the underlying mechanisms based on
the therapeutic role of TGP on the amelioration of
inflammation and oxidative stress.
Material and methods
D Dr ru ug gs s   a an nd d   a an ni im ma al ls s
Total glucosides of paeony capsules (Ningbo
Liwah Pharmaceutical CO., LTD, Zhejiang Province,
China) were dissolved in saline to a concentration
of 1.2 mg/ml. Sodium carboxymethyl cellulose 
(0.5 g; CMC-Na; Sigma, St. Louis, MO, USA) was
dissolved in 100 ml of distilled water to provide
a 0.5% (w/v) CMC-Na suspension. Biphenyldicar  -
boxylate (BDP; Dezhou Deyao Pharmaceutical CO.,
LTD, Shandong Province, China) was dissolved in
the 0.5% CMC-Na suspension to a concentration 
of  5.0  mg/ml.  Figure  1  shows  the  chemical
structures of paeoniflorin, the main component 
of TGP, and BDP .
Male  C57BL/6  mice  weighing  25-30 g  were
obtained from the Institute of Laboratory Animal
Sciences, Chinese Academy of Medical Sciences &
Peking Union Medical College (Beijing, China). The
research protocol was in accordance with the
principles approved by the animal ethics committee
of  Chinese  People’s  Liberation  Army  General
Hospital. Animals were housed at 23 ±2°C with 
a 12-h light/dark cycle and were allowed free access
to standard laboratory chow and tap water. The
mice were randomly divided into 6 groups: control,
CCl4, TGP25, TGP50, TGP100 and BDP100 groups.
The control group was intraperitoneally adminis  -
tered with the appropriate vehicles. The experi  -
mental groups were intraperitoneally injected with
CCl4 (0.5 ml/kg, 1 : 3 dilution in corn oil; Sigma) 
3 times per week for 8 weeks. The mice in groups
TGP25, TGP50 and TGP100 were given 25 mg/kg, 
50 mg/kg and 100 mg/kg TGP per day, respectively,
by gavage, twice daily for 12 weeks. The mice in the
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F Fi ig gu ur re e   1 1. .   Chemical structures of paeoniflorin (A A) and biphenyldicarboxylate (BDP) (B B)
BDP – biphenyldicarboxylate
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BDP100 group were given BDP, a positive hepato  -
protective control, at 100 mg/kg per day, once daily
by gavage for 12 weeks. In the TGP and BDP groups,
CCl4 administration was started in week 5 of admi  -
nistration and was continued to week 12 (i.e., for 
8 weeks). At the end of the treatment period, the
mice were fasted overnight and were sacrificed.
Blood was collected from the abdominal aorta and
the liver was removed and stored at –80°C for later
analysis.
M Mo ou us se e   h he ep pa at ti ic c   l li ip pi id d   p pe er ro ox xi id da at ti io on n   a an nd d   s se er ru um m
a as ss sa ay ys s
Hepatic malondialdehyde (MDA) was measured
as previously described [16-18]. In brief, 25 mg of
liver tissue was added to 250 µl of radioimmuno  -
precipitation assay (RIPA) buffer containing protease
inhibitors. This mixture was sonicated for 15 s at
40 V over ice and centrifuged at 1600 × g for 10 min
at 4°C. The supernatant was used for analysis. 
MDA was quantified using the thiobarbituric acid
reaction as described by Ohkawa [16, 17], and
measured  using  a thiobarbituric  acid  reactive
substances (TBARS) assay (Cayman Chemical Co.
Inc., MI, USA). Superoxide dismutase (SOD), nitric
oxide  synthase  (iNOS),  catalase  (CAT)  and
glutathione peroxidase (GSH) were also quantified
using appropriate assays (Cayman Chemical Co.
Inc.) [16-18].
Serum alanine aminotransferase (ALT) and aspar  -
tate  aminotransferase  (AST)  activities  were
determined using standard spectrophotometric
procedures. Serum tumour necrosis factor α (TNF-α)
was measured using an enzyme-linked immuno  -
sorbent assay (R&D Systems, Minneapolis, MN,
USA) according to the manufacturer’s protocol.
H Hi is st to ol lo og gi ic ca al l   a an nd d   i im mm mu un no oh hi is st to oc ch he em mi ic ca al l
a an na al ly ys se es s
The liver tissues were immediately fixed in 4%
paraformaldehyde,  dehydrated,  embedded  in
paraffin and sectioned. Formalin-fixed, paraffin-
embedded sections were cut and mounted on glass
slides. Sections (5 µm thick) were deparaffinised in
xylene and stained with haematoxylin and eosin
(H&E) as described by Mihailovic et al. [19]. The
immunohistochemical  evaluation  method  was
performed as described elsewhere [20]. Briefly,
sections  (5  µm  thick)  were  cut from paraffin-
embedded testis tissues and mounted on slides.
After deparaffinization and rehydration, they were
placed in a 10-mM citrate buffer (pH 6.0), followed
by  heating  in  a microwave  oven  for  antigen
retrieval. For this, three periods of 5 min each were
used, after which the sections were treated with
3% H2O2 in PBS (pH 7.6) for 20 min. The sections
were  then  incubated  overnight  at  4°C  in  PBS
containing 3% BSA and antibodies. Antibodies
against TNF-α and nuclear factor κ light chain
enhancer in B cells p65 (NF-κB p65) (Santa Cruz
Biotechnology Inc., Santa Cruz, CA, USA) were used
at 1 : 100 and 1 : 200 dilution, respectively. The
bound  primary  antibody  was  detected  using
biotinylated rabbit anti-mouse antibody (Zhongshan
Golden  Bridge,  Beijing,  China),  and  visualised 
using 3’,3’-diaminobenzidine tetrahydrochloride.
Sections were slightly counterstained with Mayer’s
haematoxylin and mounted.
R Re ea al l- -t ti im me e   r re ev ve er rs se e   t tr ra an ns sc cr ri ip pt ti io on n- -p po ol ly ym me er ra as se e
c ch ha ai in n   r re ea ac ct ti io on n   ( (q qR RT T- -P PC CR R) )
Total RNA was extracted from the livers, isolated
and purified with TRIzol reagent (Invitrogen, Carlsbad,
CA,  USA)  and  NucleoSpin® RNA  clean-up  kit
(Macherey-Nagel, Duren, Germany). Messenger RNA
(mRNA) analysis was carried out by qRT-PCR using
LightCycler technology (Roche Diagnostics, India  -
napolis,  IN,  USA)  for  continuous  fluorescence
detection. Complementary DNA (cDNA) was prepared
for qPCR analyses using the M-MLV reverse trans  -
criptase enzyme (Invitrogen-Gibco, Carlsbad, CA, USA)
and random hexamers as primers, as described 
[21-23]. The primers for mouse TNF-α, inducible nitric
oxide synthase (iNOS), cyclooxy  ge  nase-2 (COX-2), and
haem  oxygenase-1  (HO-1)  mRNA  were  used  as
previously reported [21-23]. The fol  lowing sense 
and anti-sense primers were used for amplifi  -
cation:  TNF-α,  5’-CTACTCCCAGGTTCTCTTCAA-3’ 
and 5’-GCAGAGAGGAGGTTGACTTTC-3’ [21]; iNOS, 
5’-CAGCTGGGCTGTACAAACCTT-3’ and 5’-CATTGG  -
AAGTGAAGCGTTTCG-3’ [21]; COX-2, 5’-TTCAAATGA  -
GATTGTGGAAAAAT-3’ and 5’-AGATCATCTCTGCCTGA  -
GTATCTT-3’ [22]; HO-1, 5’-CGCCTTCCTGCTCAACATT-3’
and 5’-TGTGTTCCTCTGTCAGCATCAC-3’ [23], res  -
pectively. The reactions were performed using
a LightCycler FastStart DNA Master SYBR Green I Kit
(Roche  Applied  Science)  according  to  the
manufacturer’s  instructions.  The  PCR  reaction
conditions and the annealing temperature were as
previously described [21-23]. β-Actin was used as
a reference  control  gene  to  normalize  the
expression value of each gene [24]. The experiment
was performed in triplicate for each gene, and the
average  expression  value  was  computed  for
subsequent analysis. The results were compared
using the 2-∆∆CT method [25] and are expressed as
log2 means ± SD.
W We es st te er rn n   b bl lo ot tt ti in ng g
Liver whole protein was extracted and used for
western  blotting,  which  was  performed  as
previously described [25]. Appropriate amounts of
the  protein  extracts  were  fractionated  by
electrophoresis in 6-12% SDS-polyacrylamide gels
Ying Qin, Ya-ping TianArch Med Sci 4, August / 2011 607
and transferred to nylon membranes. The nylon
membranes containing the transferred proteins
were pretreated with 1.0% non-fat dried milk in
50 mM Tris (pH 8.0) and then incubated overnight
with primary mouse monoclonal antibodies (Santa
Cruz  Biotechnology  Inc.)  against  iNOS,  COX-2, 
HO-1  and  cytochrome  P450  2E1  (CYP2E1), 
at dilutions 1 : 300, 1 : 200, 1 : 500 and 1 : 400,
respec  tively. The membranes were washed and
incubated with anti-mouse secondary antibodies
(Zhongshan Golden Bridge Biotechnology, Beijing,
China) and immunoreactivity was visualised by
exposing X-ray film to blots incubated with ECL
reagent (Amersham Biosciences, Piscataway, NJ,
USA). Results were quantified using Image-Pro Plus
software version 6.0 (Media Cybernetics Incor  -
porated, Silver Spring, MD, USA).
S St ta at ti is st ti ic ca al l   a an na al ly ys si is s
Each experiment was performed at least 3 times.
Data are means ± standard deviation. Statistical
analyses were performed by SPSS software (version
13.0, SPSS Inc., Chicago, IL, USA). One-way ANOVA
with post hoc analysis using Bonferroni’s method
or Kruskal-Wallis H test on ranks was used for
analysing results from different groups. Value of 
p < 0.05 was considered statistically significant.
Results
S Se er ru um m   T TN NF F- -α l le ev ve el l   a an nd d   a am mi in no ot tr ra an ns sf fe er ra as se e
a ac ct ti iv vi it ti ie es s
The serum TNF-α level was 8.5 ±2.2 pg/ml in the
control group. In contrast, the serum TNF-α level was
increased  by  almost  4-fold  by  CCl4,  which  was
significantly attenuated by TGP . The serum ALT and
AST activities in the control group were 40.5 ±10.9 U/l
and 68.0 ±12.9 U/l, respectively, and were markedly
increased by CCl4 treatment. These increases were
inhibited by treatment with 25 mg/kg, 50 mg/kg
and 100 mg/kg TGP (Figure 2).
S Se er ru um m   l li ip pi id d   p pe er ro ox xi id da at ti io on n
The  serum  MDA  level  was  significantly
increased in the CCl4-treated mice compared with
the control group, and was attenuated by TGP or
BDP. Similar to the MDA activities, the iNOS level
was significantly increased in the CCl4-treated
mice, and was attenuated by all doses of TGP 
and  by  BDP.  The  serum  SOD  activity  in  the 
CCl4-injected mice decreased to about 60% of the
control value but this decrease was attenuated
by all three doses of TGP. Changes in iNOS, CAT
and GSH activities showed similar trends to that
of SOD (Figure 3).
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F Fi ig gu ur re e   2 2. .   Serum ALT (A A), AST (B B) and TNF-α (C C) levels
after 8 weeks of CCl4 treatment. Values are means
± SD of six mice per group. Significantly different 
(p < 0.05) from the control group. Means without
a common letter differ at p < 0.05
CCl4 – CCl4 group, CCl4 + T25 – TGP 25 group, 
CCl4 + T50 – TGP 50 group, CCl4 + T100 – TGP 100 group
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H Hi is st to ol lo og gi ic ca al l   a an nd d   i im mm mu un no oh hi is st to oc ch he em mi ic ca al l
a an na al ly ys se es s
Mice became lethargic and lean, and their fur
became lustreless in the CCl4-treated group by 
8 weeks of treatment. Liver samples were stained
with H&E to evaluate histopathological changes.
The liver of mice in the control group showed
a normal hepatic lobular architecture and cellular
structure. In contrast, the histopathological analysis
of the liver of mice from the CCl4-treated group
showed extensive hepatocellular damage, with the
presence of portal inflammation, marked neutro  -
philic  infiltration,  extensive  fatty  changes,
centrizonal necrosis, Kupffer cell hyperplasia and
hepatic fibrosis. These histopathological changes
were ameliorated by daily administration of TGP or
BDP for 12 weeks (Figure 4).
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F Fi ig gu ur re e   3 3. .   Hepatic MDA and lipid peroxidation after 
8 weeks of CCl4 treatment. Hepatic MDA (A A), and
serum SOD (B B), iNOS (C C), CAT (D D) and GSH (E E) levels
are shown. Values are means ± SD of six mice per
group. Significantly different (p < 0.05) from the
control group. Means without a common letter differ
at p < 0.05
CCl4 – CCl4 group, CCl4 + T25 – TGP 25 group, 
CCl4 + T25 – TGP 50 group, CCl4 + T100 – TGP 100 group
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Immunohistochemistry  was  performed  to
determine the changes in intrahepatic TNF-α and
NF-κB  p65  expression  in  the  liver  after  CCl4
inducement.  We  found  that  TGP  significantly
reduced the hepatic expression of both proteins
compared with the CCl4-treated mice. As shown in
Figure 5, daily administration of 100 mg/kg TGP for
12 weeks reduced the expression of TNF-α and 
NF-κB p65 in the liver and improved the histo  -
pathological changes and tissue fibrosis compared
with mice treated with CCl4 alone.
T TN NF F- -α, ,   i iN NO OS S, ,   C CO OX X- -2 2   a an nd d   H HO O- -1 1   m mR RN NA A
e ex xp pr re es ss si io on n
Hepatic TNF-α, iNOS, COX-2, and HO-1 mRNA
expression were quite low in the control group.
However, the mRNA expression levels of these genes
were greatly  increased by CCl4 administration. 
The increase in the expression of TNF-α and iNOS
mRNA was suppressed by all three doses of TGP,
whereas the mRNA expression of COX-2 was not
affected by TGP . The mRNA expression of HO-1 was
increased by TGP (Figure 6).
i iN NO OS S, ,    C CO OX X- -2 2, ,    H HO O- -1 1    a an nd d    C CY YP P2 2E E1 1    p pr ro ot te ei in n
e ex xp pr re es ss si io on n
The protein expression of iNOS and COX-2 was
significantly higher in the CCl4-treated mice than
in the control mice. The increase in the protein
expression of iNOS and CYP2E1 was significantly
suppressed by 100 mg/kg TGP; however, TGP had
little effect on COX-2 protein expression, consistent
with the changes in mRNA expression. The protein
expression of HO-1 was significantly higher in the
CCl4-treated group than in the control group, and
this increase was augmented by 100 mg/kg TGP
(Figure 7).
Discussion
In this study, we investigated the protective
effects of TGP on CCl4-induced experimental liver
injury in mice, and the underlying mechanism. It is
generally accepted that CCl4-induced hepatotoxicity
involves the metabolism of CCl4 by cytochrome
P450 and the activation of Kupffer cells. The former
leads to the generation of free radicals and lipid
peroxidation,  which  may  actuate  the  later.
A A B B
C C D D
F Fi ig gu ur re e   4 4. . Effects of TGP on histological changes in the liver induced by CCl4 treatment for 8 weeks. A A – the control
group shows normal lobular architecture and cell structure. B B – the CCl4-treated group shows extensive hepatocellular
damage with the presence of portal inflammation, centrizonal necrosis, and Kupffer cell hyperplasia. C C – mild portal
inflammation, little hepatocellular necrosis and Kupffer cell hyperplasia are present in the 100 mg/kg TGP group. 
D D – there were no marked improvements in CCl4-induced liver injury in the 100 mg/kg BDP group. Bars, 100 µm
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A A B B
C C D D
Meanwhile,  the  activation  of  Kupffer  cells  is
accompanied by the production of proinflammatory
mediators [27, 28].
Total glucosides of paeony is relatively inexpen  -
sive, with negligible side effects, and shows great
potential in the treatment of liver diseases. Previous
studies have demonstrated that the antioxidative
effects of TGP are mediated by the inhibition of
thiobarbituric acid (TBA) reactive substance, an
index  of  endogenous  lipid  peroxidation,  and
enhanced activities of antioxidant enzymes such
as superoxide dismutase, catalase and glutathione
peroxidase  following  cerebral  ischaemia  and
immunological liver injury [29].
During hepatic injury, deteriorated integrity of
the cellular membrane causes release of enzymes
into  the  circulation,  reflecting  damage  to  the
hepatic cells [30]. Thus, abnormally high levels of
serum hepatospecific enzymes such as ALT and AST
are regarded as good biomarkers for liver injury. We
found that TGP inhibited the elevations of ALT and
AST in CCl4-induced liver injury. The attenuated
increase in serum ALT and AST levels suggests that
TGP  improved  the  structural  integrity  of  the
hepatocellular membrane, thus protecting mice
against CCl4-induced hepatotoxicity. Histological
analyses showed that CCl4 caused a variety of
histological  changes  in  the  liver,  including
centrizonal necrosis, portal inflammation, Kupffer
cell hyperplasia, extensive fatty changes, and even
hepatic  fibrosis  and  cirrhosis.  These  histo  -
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F Fi ig gu ur re e   6 6. .   Effects of 100 mg/kg TGP on the mRNA
expression of iNOS, COX-2 and HO-1 in the liver of
CCl4-treated mice. Values are means ± SD of five
mice per group. Significantly different (p < 0.05) from
the control group. Means without a common letter
differ at p < 0.05
T100 – TGP 100 group, BDP100 – BDP 100 group
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F Fi ig gu ur re e   5 5. . Immunohistochemical analyses showed that TGP suppressed the increased TNF-α and NF-κB 65 expression
induced by 8 weeks of CCl4 treatment. A A – TNF-α expression in the CCl4-treated group, B B – the 100 mg/kg 
TGP-treated group, C C – NF-κB 65 expression in the CCl4-treated group, D D –  the 100 mg/kg TGP-treated group. Bars,
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pathological changes were significantly attenuated
by TGP. Our findings suggest that the hepato  -
protective effect of TGP was better or at least the
same as that of BDP, a potent hepatoprotective
agent. Although BDP has a marked ALT-lowering
effect [31], this is transient and relapse is likely.
Hence, its clinical application is limited. The present
results suggest that TGP could be used to treat liver
diseases.
Previous  studies  have  indicated  that  the
induction of CYP2E1 by CCl4 in vivo leads to the
generation of trichloromethyl free radicals and ROS,
which initiate lipid peroxidation [32]. In turn, lipid
peroxidation stimulates the expression of TNF-α
and  inflammatory  mediators  (e.g.,  iNOS  and 
COX-2), and activates the signalling pathways that
are classically associated with inflammation, such
as NF-κB, which might in turn further trigger the
production of toxic compounds such as ROS or nitric
oxide (NO), inflammatory cytokines and glutamate,
thus causing liver damage [33]. Enhanced anti  -
oxidant activity may be one mechanism through
which drugs may protect against CCl4-induced liver
injury.
A recent report suggested that TGP ameliorated
immunological hepatic fibrosis in rats caused by
inhibitory  oxidation  and  nitration  [34].  In  the
present study, TGP inhibited CYP2E1 expression and
consequently suppressed the increase in gene
expression of TNF-α and iNOS, suggesting that TGP
regulates CCl4-induced production of TNF-α and
iNOS at the transcriptional level. Total glucosides
of paeony blocked the CCl4-mediated oxidative
stress  and  lipid  peroxidation  by  signi  ficantly
reducing the levels of by-products of lipid oxidation
(i.e.,  hepatic  MDA)  and  serum  CAT  levels,
suppressing the activities of serum SOD and GSH,
and  inhibiting  the  increase  in  TNF-α levels.
Concomitantly,  the  increased  protein  level  of 
NF-κB was reduced by TGP treatment. These results
indicate that TGP exerted its hepatoprotective
effects by improving de novo protein synthesis,
particularly  of  HO-1,  and  counteracting  the
increased formation of free radicals. Moreover, 
HO-1 is believed to play an important protective role
against oxidative injury [35]. Overexpression of 
HO-1  might  be  closely  associated  with  the
protective mechanism of some molecules against
CCl4-induced hepatic injury. Our findings suggest
that  the  gene  expression  of  HO-1  increased
markedly within 24 h after CCl4 administration, and
was maintained to the end of the study, comprising
an important mechanism in the protective effects
of TGP in CCl4-induced liver injury. However, in this
study, the gene and protein expression of COX-2
increased significantly in response to CCl4 and was
not affected by TGP. More studies are needed to
examine this effect in more detail and explore the
underlying mechanisms. Meanwhile, the physiology
and biochemistry of rodents are somewhat different
from those observed in people. Further experi  mental
studies  in  both  the  redones  and  humans  and
subsequently all phases of clinical trials in humans
are also required before TGP is used in clinical study.
In  conclusion,  TGP  protects  the  liver  from 
CCl4-induced oxidative stress and the inflammatory
response, without any known side effects. While
the applicability of the findings of this work is very
far from any conceivable clinical application in
humans, the possible role of TGP as a promising
therapeutic  in  human  oxidative  stress  and
inflammatory  liver  disease  deserves  further
consideration. The potential for TGP in experimental
and practical applications should be examined in
future studies.
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